Table 1 Patient characteristics according to the presence and absence of pharmacist intervention requirements
From: Development of clinical pharmacy services for intensive care units in Korea
Total (n = 1,344) | Required pharmacist intervention | P-value | |||
|---|---|---|---|---|---|
Yes (n = 445) | No (n = 899) | ||||
Age, median (range), y | 64.0 (10–95) | 64.0 (18–94) | 64.0 (10–95) | 0.648 | |
Sex, n (%) | 0.367 | ||||
Male | 856 | 291 (65.4) | 565 (62.8) | ||
Female | 488 | 154 (34.6) | 334 (37.2) | ||
Clinical departments, n (%) | <0.001 | ||||
Gastroenterology | 139 | 19 (4.3) | 120 (13.3) | ||
Pulmonary | 423 | 164 (36.9) | 259 (28.8) | ||
Nephrology | 84 | 19 (4.3) | 65 (7.2) | ||
Hematology & Oncology | 521 | 189 (42.5) | 332 (36.9) | ||
Infectious Diseases | 98 | 31 (7.0) | 67 (7.5) | ||
Others | 79 | 23 (5.2) | 56 (6.2) | ||
Length of hospital stay, median (range), day1 | 4.0 (1–195) | 9.0 (1–195) | 2.0 (1–109) | <0.001 | |
Clinical conditions, n (%) | |||||
Renal dysfunction | <0.001 | ||||
Yes | 419 | 173 (38.9) | 246 (27.4) | ||
No | 925 | 272 (61.1) | 653 (72.6) | ||
Hepatic dysfunction | 0.062 | ||||
Yes | 225 | 62 (13.9) | 163 (18.1) | ||
No | 1,119 | 383 (86.1) | 736 (81.9) | ||